Published ahead of print on July 21, 2004, doi:10.1164/rccm.200305-617OC
American Journal of Respiratory and Critical Care Medicine Vol 170. pp. 870-878, (2004)
© 2004 American Thoracic Society
doi: 10.1164/rccm.200305-617OC
Effects of Testosterone and Resistance Training in Men with Chronic Obstructive Pulmonary Disease
Richard Casaburi,
Shalender Bhasin,
Louis Cosentino,
Janos Porszasz,
Attila Somfay,
Michael I. Lewis,
Mario Fournier and
Thomas W. Storer
Division of Endocrinology and Molecular Medicine, Drew University of Medicine and Science; Division of Pulmonary and Critical Care Medicine, Cedars-Sinai Medical Center, Los Angeles; Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and Exercise Sciences Laboratory, El Camino College, Torrance, California
Correspondence and requests for reprints should be addressed to Richard Casaburi, Ph.D., M.D., Division of Respiratory and Critical Care Physiology and Medicine, Los Angeles Biomedical Research Institute, Building RB2, 1124 West Carson Street, Torrance, CA 90502. E-mail: casaburi{at}ucla.edu
Dysfunction of the muscles of ambulation contributes to exercise intolerance in chronic obstructive pulmonary disease (COPD). Men with COPD have high prevalence of low testosterone levels, which may contribute to muscle weakness. We determined effects of testosterone supplementation (100 mg of testosterone enanthate injected weekly) with or without resistance training (45 minutes three times weekly) on body composition and muscle function in 47 men with COPD (mean FEV1 = 40% predicted) and low testosterone levels (mean = 320 ng/dl). Subjects were randomized to 10 weeks of placebo injections + no training, testosterone injections + no training, placebo injections + resistance training, or testosterone injections + resistance training. Testosterone injections yielded a mean increase of 271 ng/dl in the nadir serum testosterone concentration (to the middle of the normal range for young men). The lean body mass (by dual-energy X-ray absorptiometry) increase averaged 2.3 kg with testosterone alone and 3.3 kg with combined testosterone and resistance training (p < 0.001). Increase in one-repetition maximum leg press strength averaged 17.2% with testosterone alone, 17.4% with resistance training alone, and 26.8% with testosterone + resistance training (p < 0.001). Interventions were well tolerated with no abnormalities in safety measures. Further studies are required to determine long-term benefits of adding testosterone supplementation and resistance training to rehabilitative programs for carefully screened men with COPD and low testosterone levels.
Key Words: androgenic steroid inflammation muscle mass strength
This article has been cited by other articles:

|
 |

|
 |
 
G. H Markovitz and C. B Cooper
Review series: Rehabilitation in non COPD: Mechanisms of exercise limitation and pulmonary rehabilitation for patients with pulmonary fibrosis/restrictive lung disease
Chronic Respiratory Disease,
February 1, 2010;
7(1):
47 - 60.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Srinivas-Shankar, S. A. Roberts, M. J. Connolly, M. D. L. O'Connell, J. E. Adams, J. A. Oldham, and F. C. W. Wu
Effects of Testosterone on Muscle Strength, Physical Function, Body Composition, and Quality of Life in Intermediate-Frail and Frail Elderly Men: A Randomized, Double-Blind, Placebo-Controlled Study
J. Clin. Endocrinol. Metab.,
February 1, 2010;
95(2):
639 - 650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. O'Shea, N. F. Taylor, and J. D. Paratz
Progressive Resistance Exercise Improves Muscle Strength and May Improve Elements of Performance of Daily Activities for People With COPD: A Systematic Review
Chest,
November 1, 2009;
136(5):
1269 - 1283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Laghi, N. Adiguzel, and M. J. Tobin
Endocrinological derangements in COPD
Eur. Respir. J.,
October 1, 2009;
34(4):
975 - 996.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-A. Caron, R. Debigare, P. N. R. Dekhuijzen, and F. Maltais
Comparative assessment of the quadriceps and the diaphragm in patients with COPD
J Appl Physiol,
September 1, 2009;
107(3):
952 - 961.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Langer, E. Hendriks, C. Burtin, V. Probst, C. van der Schans, W. Paterson, M. Verhoef-de Wijk, R. Straver, M. Klaassen, T. Troosters, et al.
A clinical practice guideline for physiotherapists treating patients with chronic obstructive pulmonary disease based on a systematic review of available evidence
Clinical Rehabilitation,
May 1, 2009;
23(5):
445 - 462.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Casaburi and R. ZuWallack
Pulmonary Rehabilitation for Management of Chronic Obstructive Pulmonary Disease
N. Engl. J. Med.,
March 26, 2009;
360(13):
1329 - 1335.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Sharma, A Arneja, L McLean, D Duerksen, W Leslie, D Sciberras, and M Lertzman
Anabolic steroids in COPD: a review and preliminary results of a randomized trial
Chronic Respiratory Disease,
August 1, 2008;
5(3):
169 - 176.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Maltais, D. Saey, and R. Debigare
Enhancing the Benefits of Pulmonary Rehabilitation: Doing More for a Few or Doing a Little Less for Many?
Am. J. Respir. Crit. Care Med.,
August 1, 2008;
178(3):
215 - 216.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Albert and P. M. A. Calverley
Drugs (including oxygen) in severe COPD
Eur. Respir. J.,
May 1, 2008;
31(5):
1114 - 1124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. King, F. Cordova, and S. M. Scharf
Nutritional Aspects of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
May 1, 2008;
5(4):
519 - 523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Casaburi
Boosting the Effectiveness of Rehabilitative Exercise Training
Am. J. Respir. Crit. Care Med.,
April 15, 2008;
177(8):
805 - 806.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. G. Collins, W. E. Langbein, L. Fehr, S. O'Connell, C. Jelinek, E. Hagarty, L. Edwards, D. Reda, M. J. Tobin, and F. Laghi
Can Ventilation-Feedback Training Augment Exercise Tolerance in Patients with Chronic Obstructive Pulmonary Disease?
Am. J. Respir. Crit. Care Med.,
April 15, 2008;
177(8):
844 - 852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al.
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Eur. Respir. J.,
February 1, 2008;
31(2):
416 - 469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. R Gosker, M. P Zeegers, E. F M Wouters, and A. M W J Schols
Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis
Thorax,
November 1, 2007;
62(11):
944 - 949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. I. Lewis, M. Fournier, T. W. Storer, S. Bhasin, J. Porszasz, S.-G. Ren, X. Da, and R. Casaburi
Skeletal muscle adaptations to testosterone and resistance training in men with COPD
J Appl Physiol,
October 1, 2007;
103(4):
1299 - 1310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Ries, G. S. Bauldoff, B. W. Carlin, R. Casaburi, C. F. Emery, D. A. Mahler, B. Make, C. L. Rochester, R. ZuWallack, and C. Herrerias
Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines
Chest,
May 1, 2007;
131(5_suppl):
4S - 42S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C Steiner
Sarcopaenia in chronic obstructive pulmonary disease
Thorax,
February 1, 2007;
62(2):
101 - 103.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Haddad, C. C. Kennedy, S. M. Caples, M. J. Tracz, E. R. Bolona, K. Sideras, M. V. Uraga, P. J. Erwin, and V. M. Montori
Testosterone and Cardiovascular Risk in Men: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials
Mayo Clin. Proc.,
January 1, 2007;
82(1):
29 - 39.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Katznelson, M. W Robinson, C. L Coyle, H. Lee, and C. E Farrell
Effects of modest testosterone supplementation and exercise for 12 weeks on body composition and quality of life in elderly men
Eur. J. Endocrinol.,
December 1, 2006;
155(6):
867 - 875.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Casaburi
Impacting patient-centred outcomes in COPD: deconditioning
Eur. Respir. Rev.,
December 1, 2006;
15(99):
42 - 46.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Nici, C. Donner, E. Wouters, R. Zuwallack, N. Ambrosino, J. Bourbeau, M. Carone, B. Celli, M. Engelen, B. Fahy, et al.
American thoracic society/european respiratory society statement on pulmonary rehabilitation.
Am. J. Respir. Crit. Care Med.,
June 15, 2006;
173(12):
1390 - 1413.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe
Update in chronic obstructive pulmonary disease 2005.
Am. J. Respir. Crit. Care Med.,
May 15, 2006;
173(10):
1056 - 1065.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Spruit, R. Gosselink, T. Troosters, A. Kasran, M. Van Vliet, and M. Decramer
Low-Grade Systemic Inflammation and the Response to Exercise Training in Patients With Advanced COPD
Chest,
November 1, 2005;
128(5):
3183 - 3190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Laghi
Low Testosterone in Chronic Obstructive Pulmonary Disease: Does It Really Matter?
Am. J. Respir. Crit. Care Med.,
November 1, 2005;
172(9):
1069 - 1070.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Van Vliet, M. A. Spruit, G. Verleden, A. Kasran, E. Van Herck, F. Pitta, R. Bouillon, and M. Decramer
Hypogonadism, Quadriceps Weakness, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
November 1, 2005;
172(9):
1105 - 1111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Puhan and H. J. Schunemann
Testosterone Supplementation during Respiratory Rehabilitation
Am. J. Respir. Crit. Care Med.,
August 1, 2005;
172(3):
399 - 399.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Casaburi, L. Cosentino, J. Porszasz, M. I. Lewis, M. Fournier, and T. W. Storer
Testosterone Supplementation during Respiratory Rehabilitation
Am. J. Respir. Crit. Care Med.,
August 1, 2005;
172(3):
399 - 400.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Troosters, R. Casaburi, R. Gosselink, and M. Decramer
Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
July 1, 2005;
172(1):
19 - 38.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Barnes and R. A. Stockley
COPD: current therapeutic interventions and future approaches
Eur. Respir. J.,
June 1, 2005;
25(6):
1084 - 1106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Fabbri, S. P. Peters, I. Pavord, S. E. Wenzel, S. C. Lazarus, W. MacNee, F. Lemaire, and E. Abraham
Allergic Rhinitis, Asthma, Airway Biology, and Chronic Obstructive Pulmonary Disease in AJRCCM in 2004
Am. J. Respir. Crit. Care Med.,
April 1, 2005;
171(7):
686 - 698.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Laghi, W. E. Langbein, A. Antonescu-Turcu, A. Jubran, C. Bammert, and M. J. Tobin
Respiratory and Skeletal Muscles in Hypogonadal Men with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
March 15, 2005;
171(6):
598 - 605.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 American Thoracic Society
|
|
|